November 17, 2018: Hilliard filed a lawsuit against Gilead Sciences, Inc., the maker of tenofovir disoproxil fumarate (TDF). The anti-viral drug is prescribed for pre-exposure prophylaxis (PreP) to prevent the user from contracting HIV and also to treat HIV. The class action suit was filed on behalf of people who took the drug and experienced bone damage and/or kidney damage.